• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于内在亚型的乳腺癌磁共振成像特征:与新辅助化疗效果的相关性

Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects.

作者信息

Kawashima Hiroko, Inokuchi Masafumi, Furukawa Hiroyuki, Ikeda Hiroko, Kitamura Seiko

机构信息

Department of Quantum Medical Technology, Graduate School of Medical Science, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, 920-0942 Japan ; Section of Breast Oncology, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641 Japan.

Section of Breast Oncology, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641 Japan.

出版信息

Springerplus. 2014 May 9;3:240. doi: 10.1186/2193-1801-3-240. eCollection 2014.

DOI:10.1186/2193-1801-3-240
PMID:24892001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4039660/
Abstract

PURPOSE

The purpose of this study was to evaluate the magnetic resonance imaging (MRI) features of breast cancer according to intrinsic subtypes and to investigate whether the MRI and immunohistochemical findings were related to neoadjuvant chemotherapy (NAC) effects.

MATERIALS AND METHODS

The MRI in 116 women with breast cancers who underwent NAC was reviewed. The mass margin, presence of intratumoral necrosis, tumor extension around the mass, relative signal enhancement (RSE), and kinetic curve pattern were analyzed. We investigated the possible correlations between MRI findings and the effects of NAC.

RESULTS

An irregular mass margin was significantly associated with luminal-A cancers, while a smooth mass margin was associated with human epidermal growth factor receptor2 (HER2) cancers. Intratumoral necrosis was significantly associated with triple-negative cancers. Tumor extension around the mass was significantly infrequent in luminal-B cancers and frequent in HER2 cancers. Luminal-B and HER2 cancers showed a significantly higher RSE at 2 min than Luminal-A cancers. Estrogen receptor (ER)-positive cancers, HER2-negative cancers, and presence of intratumoral necrosis were significantly associated with the NAC non-response.

CONCLUSIONS

Several MR features can be used to predict the intrinsic subtype of breast cancers. ER-positivity, HER2-negativity, and presence of intratumoral necrosis were significantly associated with NAC non-response.

摘要

目的

本研究旨在根据内在亚型评估乳腺癌的磁共振成像(MRI)特征,并探讨MRI和免疫组化结果是否与新辅助化疗(NAC)效果相关。

材料与方法

回顾了116例接受NAC的乳腺癌女性患者的MRI检查结果。分析了肿块边缘、瘤内坏死情况、肿块周围肿瘤扩展情况、相对信号增强(RSE)以及动态曲线模式。我们研究了MRI表现与NAC效果之间的可能相关性。

结果

肿块边缘不规则与腔面A型癌症显著相关,而肿块边缘光滑与人类表皮生长因子受体2(HER2)型癌症相关。瘤内坏死与三阴性癌症显著相关。肿块周围的肿瘤扩展在腔面B型癌症中显著少见,而在HER2型癌症中常见。腔面B型和HER2型癌症在2分钟时的RSE显著高于腔面A型癌症。雌激素受体(ER)阳性癌症、HER2阴性癌症以及瘤内坏死的存在与NAC无反应显著相关。

结论

几种MRI特征可用于预测乳腺癌的内在亚型。ER阳性、HER2阴性以及瘤内坏死的存在与NAC无反应显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/031b7387a8dc/40064_2014_970_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/be6bfda4ef15/40064_2014_970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/1cff7650595c/40064_2014_970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/73d72c9dce3a/40064_2014_970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/3a60a444dc69/40064_2014_970_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/7b80f8a94a65/40064_2014_970_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/031b7387a8dc/40064_2014_970_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/be6bfda4ef15/40064_2014_970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/1cff7650595c/40064_2014_970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/73d72c9dce3a/40064_2014_970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/3a60a444dc69/40064_2014_970_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/7b80f8a94a65/40064_2014_970_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/4039660/031b7387a8dc/40064_2014_970_Fig6_HTML.jpg

相似文献

1
Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects.基于内在亚型的乳腺癌磁共振成像特征:与新辅助化疗效果的相关性
Springerplus. 2014 May 9;3:240. doi: 10.1186/2193-1801-3-240. eCollection 2014.
2
Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.管腔B型、人表皮生长因子受体2(HER2/neu)型和三阴性乳腺癌在新辅助治疗后比管腔A型乳腺癌具有更好的化疗反应。
Cureus. 2023 Jun 6;15(6):e40066. doi: 10.7759/cureus.40066. eCollection 2023 Jun.
3
Triple-negative breast cancer: are the imaging findings different between responders and nonresponders to neoadjuvant chemotherapy?三阴性乳腺癌:新辅助化疗的应答者和无应答者的影像学表现是否不同?
Acad Radiol. 2011 Aug;18(8):963-9. doi: 10.1016/j.acra.2011.04.002. Epub 2011 Jun 11.
4
Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.扩散加权成像在评估乳腺癌亚型肿瘤对新辅助化疗的病理反应中的应用
J Magn Reson Imaging. 2015 Sep;42(3):779-87. doi: 10.1002/jmri.24843. Epub 2015 Jan 8.
5
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.基于乳腺动态对比增强磁共振成像的瘤内和瘤周影像组学对新辅助化疗病理完全缓解的治疗前预测
Breast Cancer Res. 2017 May 18;19(1):57. doi: 10.1186/s13058-017-0846-1.
6
Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.MRI乳腺影像报告和数据系统(BI-RADS)术语描述符与乳腺癌分子亚型之间的关系:内部强化与管腔B亚型相关。
Breast J. 2017 Sep;23(5):579-582. doi: 10.1111/tbj.12799. Epub 2017 Mar 13.
7
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.HER2(ERBB2)阳性乳腺癌术前靶向治疗的肿瘤生物学和病理反应与肿瘤周围放射组学的相关性。
JAMA Netw Open. 2019 Apr 5;2(4):e192561. doi: 10.1001/jamanetworkopen.2019.2561.
8
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.新辅助化疗后通过MRI分析完全缓解情况,对乳腺癌分子亚型的病理肿瘤反应预测有所不同。
Oncol Lett. 2013 Jan;5(1):83-89. doi: 10.3892/ol.2012.1004. Epub 2012 Oct 30.
9
Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer.在雌激素受体(ER)阳性、人表皮生长因子受体2(HER2)阴性乳腺癌中,生存与新辅助化疗后MRI上的完全缓解相关。
Breast Cancer Res. 2016 Aug 5;18(1):82. doi: 10.1186/s13058-016-0742-0.
10
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.三阴性悖论:乳腺癌亚型的原发性肿瘤化疗敏感性
Clin Cancer Res. 2007 Apr 15;13(8):2329-34. doi: 10.1158/1078-0432.CCR-06-1109.

引用本文的文献

1
The association of magnetic resonance imaging features with five molecular subtypes of breast cancer.磁共振成像特征与乳腺癌五种分子亚型的关联。
Eur J Radiol Open. 2024 Jun 28;13:100585. doi: 10.1016/j.ejro.2024.100585. eCollection 2024 Dec.
2
Intra- and peritumoral radiomics features based on multicenter automatic breast volume scanner for noninvasive and preoperative prediction of HER2 status in breast cancer: a model ensemble research.多中心自动乳腺容积扫描仪的肿瘤内和肿瘤周围放射组学特征用于非侵入性和术前预测乳腺癌 HER2 状态:模型集成研究。
Sci Rep. 2024 Feb 29;14(1):5020. doi: 10.1038/s41598-024-55838-4.
3

本文引用的文献

1
Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes.浸润性乳腺癌的定量MRI形态学:与免疫组化生物标志物及亚型的相关性
Acta Radiol. 2015 Mar;56(3):269-75. doi: 10.1177/0284185114524197. Epub 2014 Feb 20.
2
Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer.乳腺癌中动力学参数分布的瘤内异质性:基于浸润性乳腺癌分子亚型的比较。
Breast Cancer. 2015 Sep;22(5):496-502. doi: 10.1007/s12282-013-0512-0. Epub 2014 Jan 9.
3
Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy.
[Evaluation of Post-Neoadjuvant Chemotherapy Pathologic Complete Response and Residual Tumor Size of Breast Cancer: Analysis on Accuracy of MRI and Affecting Factors].
[新辅助化疗后乳腺癌病理完全缓解及残余肿瘤大小的评估:MRI准确性及影响因素分析]
Taehan Yongsang Uihakhoe Chi. 2021 May;82(3):654-669. doi: 10.3348/jksr.2020.0120. Epub 2021 Mar 22.
4
Sigmoid model analysis of breast dynamic contrast-enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction.基于动态对比增强 MRI 的 Sigmoid 模型分析:鉴别乳腺良恶性肿块及乳腺癌亚型预测。
J Appl Clin Med Phys. 2022 Jun;23(6):e13651. doi: 10.1002/acm2.13651. Epub 2022 May 20.
5
Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.乳腺癌亚型与定量磁共振成像:一项系统综述
Life (Basel). 2022 Mar 28;12(4):490. doi: 10.3390/life12040490.
6
Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy.磁共振成像在评估乳腺癌新辅助化疗反应中的作用。
In Vivo. 2020 Mar-Apr;34(2):909-915. doi: 10.21873/invivo.11857.
7
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.HER2(ERBB2)阳性乳腺癌术前靶向治疗的肿瘤生物学和病理反应与肿瘤周围放射组学的相关性。
JAMA Netw Open. 2019 Apr 5;2(4):e192561. doi: 10.1001/jamanetworkopen.2019.2561.
8
Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancer.计算机辅助评估乳腺癌中 MRI 形态学与免疫组织化学标志物或分子亚型之间的相关性。
Sci Rep. 2017 Oct 23;7(1):13818. doi: 10.1038/s41598-017-14274-3.
9
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.基于乳腺动态对比增强磁共振成像的瘤内和瘤周影像组学对新辅助化疗病理完全缓解的治疗前预测
Breast Cancer Res. 2017 May 18;19(1):57. doi: 10.1186/s13058-017-0846-1.
优化后的乳腺MRI功能肿瘤体积作为新辅助化疗后无复发生存的生物标志物。
J Magn Reson Imaging. 2014 Aug;40(2):476-82. doi: 10.1002/jmri.24351. Epub 2013 Dec 18.
4
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.高时间分辨率 DCE-MRI 半定量分析早期评估新辅助化疗乳腺癌的疗效:初步结果。
Magn Reson Imaging. 2013 Nov;31(9):1457-64. doi: 10.1016/j.mri.2013.07.002. Epub 2013 Aug 15.
5
[Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].基于雌激素受体/孕激素受体(ER/PR)和人表皮生长因子受体2(Her2)表达的乳腺癌亚型:磁共振成像特征比较
Zhonghua Yi Xue Za Zhi. 2013 Mar 19;93(11):819-23.
6
Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.动态对比增强 MRI 灌注参数与乳腺癌预后因素及亚型的相关性。
J Magn Reson Imaging. 2012 Jul;36(1):145-51. doi: 10.1002/jmri.23635. Epub 2012 Mar 5.
7
Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?监测乳腺癌患者的新辅助化疗:3T 时的磁共振评估改善?
J Magn Reson Imaging. 2011 Sep;34(3):547-56. doi: 10.1002/jmri.22642. Epub 2011 Jul 14.
8
Triple-negative breast cancer: are the imaging findings different between responders and nonresponders to neoadjuvant chemotherapy?三阴性乳腺癌:新辅助化疗的应答者和无应答者的影像学表现是否不同?
Acad Radiol. 2011 Aug;18(8):963-9. doi: 10.1016/j.acra.2011.04.002. Epub 2011 Jun 11.
9
Effectiveness of dynamic contrast-enhanced magnetic resonance imaging in evaluating clinical responses to neoadjuvant chemotherapy in breast cancer.动态对比增强磁共振成像在评估乳腺癌新辅助化疗临床反应中的有效性。
Chin Med J (Engl). 2011 Jan;124(2):194-8.
10
Neoadjuvant systemic treatment of breast cancer.乳腺癌的新辅助全身治疗。
J Surg Oncol. 2011 Mar 15;103(4):348-57. doi: 10.1002/jso.21696.